Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes (START)
This study is currently recruiting participants.
Study NCT00515099 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: August 10, 2007 Last Updated: May 13, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 1
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Antithymocyte globulin
Placebo
Additional drug interventions recognized in this trial
Antilymphocyte Serum
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network
Back to top of Main Content